NK cell-mediated immunopathology during an acute viral infection of the CNS

European Journal of Immunology

Volumn 36, Issue 4, 2006, Pages 887-896

  Alsharifi, Mohammed ^a   Lobigs, Mario ^a   Simon, Markus M ^b   Kersten, Astrid ^c   Müller, Klaus ^d   Koskinen, Aulikki ^a   Lee, Eva ^a   Müllbacher, Arno ^a  

^a Biology and Environment   (Australia)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Institute of Pathology   (Germany)

Author keywords

CNS; Cytotoxicity; Immunopathology; NK cells

Indexed keywords

BETA 2 MICROGLOBULIN; FAS ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GRANULE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CONVALESCENCE; CYTOLYSIS; CYTOTOXICITY; EXOCYTOSIS; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTION CONTROL; INFECTION RESISTANCE; INFECTION SENSITIVITY; LETHALITY; MORTALITY; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; SEMLIKI FOREST ALPHAVIRUS; T LYMPHOCYTE; VIRUS INFECTION; VIRUS VIRULENCE; WILD TYPE;

ALPHAVIRUS INFECTIONS; ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; SEMLIKI FOREST VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33645926371     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535342     Document Type: Article

References (51)

1. Trapani, J. A. and Smyth, M. J., Functional significance of the perforin/ granzyme cell death pathway. Nat. Rev. Immunol. 2002. 2: 735-747.
2. Vassalli, P., Grau, G. E. and Piguet, P. F., TNF in autoimmune diseases, graft-versus-host reactions, and pulmonary fibrosis. Immunol. Ser. 1992. 56: 409-430.
3. Boehm, U., Klamp, T., Groot, M. and Howard, J. C., Cellular responses to interferon-gamma. Annu. Rev. Immunol. 1997. 15: 749-795.
4. Kagi, D., Ledermann, B., Burki, K., Zinkernagel, R. M. and Hengartner, H., Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 1996. 14: 207-232.
5. Russell, J. H. and Ley, T. J., Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 2002. 20: 323-370.
6. Balkow, S., Kersten, A., Tran, T. T., Stehle, T., Grosse, P., Museteanu, C., Utermohlen, O. et al., Concerted action of the FasL/Fas and perforin/ granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J. Virol. 2001. 75: 8781-8791.
7. Doherty, P. C. and Zinkernagel, R. M., T-cell-mediated immunopathology in viral infections. Transplant Rev. 1974. 19: 89-120.
8. Guidotti, L. G., Borrow, P., Brown, A., McClary, H., Koch, R. and Chisari, F. V., Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J. Exp. Med. 1999. 189: 1555-1564.
9. + T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 2003. 77: 13323-13334.
10. Atkins, G. J., Sheahan, B. J. and Liljestrom, P., The molecular pathogenesis of Semliki Forest virus: a model virus made useful? J. Gen. Virol. 1999. 80 (Pt 9): 2287-2297.
11. Smithburn, K. C. and Haddow, A., Semliki Forest Virus. I. Isolation and pathogenic properties. J. Immunol. 1944. 49: 141-157.
12. McIntosh, B. M., Brookworth, C. and Kokernot, R. H., Isolation of Semliki Forest Virus from Aedes (Aedimorphus) argenteopunctatus (Theobald) collected in Portugese East Africa. Trans. R. Soc. Trop. Med. Hyg. 1961. 55: 386-393.
13. Fazakerley, J. K., Pathogenesis of Semliki Forest virus encephalitis. J. Neurovirol. 2002. 8 Suppl 2: 66-74.
14. Fazakerley, J. K. and Webb, H. E., Semliki Forest virus induced, immune mediated demyelination: the effect of irradiation. Br. J. Exp. Pathol. 1987. 68: 101-113.
15. + T cells prevents lesions of demyelination in Semliki Forest virus infection. J. Virol. 1993. 67: 7629-7633.
16. k. Immunogenetics 1978. 7: 551-561.
17. Smith-Norowitz, T. A., Sobel, R. A. and Mokhtarian, F., B cells and antibodies in the pathogenesis of myelin injury in Semliki Forest Virus encephalomyelitis. Cell. Immunol. 2000. 200: 27-35.
18. Doherty, P. C., Quantitative studies of the inflammatory process in fatal viral meningoencephalitis. Am. J. Pathol. 1973. 73: 607-622.
19. Kagi, D., Seiler, P., Pavlovic, J., Ledermann, B., Burki, K., Zinkernagel, R. M. and Hengartner, H., The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 1995. 25: 3256-3262.
20. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. and Salazar-Mather, T. P., Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999. 17: 189-220.
21. Mullbacher, A. and King, N. J., Target cell lysis by natural killer cells is influenced by beta 2-microglobulin expression. Scand. J. Immunol. 1989. 30: 21-29.
22. Vitale, M., Zimmer, J., Castriconi, R., Hanau, D., Donato, L., Bottino, C., Moretta, L. et al., Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood 2002. 99: 1723-1729.
23. Markel, G., Mussaffi, H., Ling, K. L., Salio, M., Gadola, S., Steuer, G., Blau, H. et al., The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood 2004. 103: 1770-1778.
24. Nagata, S. and Suda, T., Fas and Fas ligand: lpr and gld mutations. Immunol. Today 1995. 16: 39-43.
25. k during differentiation and stimulation converts stem cells of low responder genotype to T cells of responder phenotype. J. Exp. Med. 1979. 149: 786-790.
26. Mullbacher, A., Marshall, I. D. and Blanden, R. V., Cross-reactive cytotoxic T cells to alphavirus infection. Scand. J. Immunol. 1979. 10: 291-296.
27. Furukawa, H., Iizuka, K., Poursine-Laurent, J., Shastri, N. and Yokoyama, W. M., A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice. J. Immunol. 2002. 169: 126-136.
28. Binder, G. K. and Griffin, D. E., Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 2001. 293: 303-306.
29. + T lymphocytes is effected through the Fas /FasL, but not the perforin pathway. Eur. J. Immunol. 2000. 30: 3623-3633.
30. Medana, I., Li, Z., Flugel, A., Tschopp, J., Wekerle, H. and Neumann, H., Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity. J. Immunol. 2001. 167: 674-681.
31. Kagi, D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R. et al., Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994. 369: 31-37.
32. Mullbacher, A., Hla, R. T., Museteanu, C. and Simon, M. M., Perforin is essential for control of ectromelia virus but not related poxviruses in mice. J. Virol. 1999. 73: 1665-1667.
33. Riera, L., Gariglio, M., Valente, G., Mullbacher, A., Museteanu, C., Landolfo, S. and Simon, M. M., Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. Eur. J. Immunol. 2000. 30: 1350-1355.
34. Elkon, K. B., Liu, C. C., Gall, J. G., Trevejo, J., Marino, M. W., Abrahamsen, K. A., Song, X. et al., Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. USA 1997. 94: 9814-9819.
35. Wang, Y., Lobigs, M., Lee, E. and Mullbacher, A., Exocytosis and Fas mediated cytolytic mechanisms exert protection from West Nile virus induced encephalitis in mice. Immunol. Cell Biol. 2004. 82: 170-173.
36. Licon Luna, R. M., Lee, E., Mullbacher, A., Blanden, R. V., Langman, R. and Lobigs, M., Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice. J. Virol. 2002. 76: 3202-3211.
37. Liu, Y., Blanden, R. V. and Mullbacher, A., Identification of cytolytic lymphocytes in West Nile virus-infected murine central nervous system. J. Gen. Virol. 1989. 70: 565-573.
38. Pusztai, R., Gould, E. A. and Smith, H., Infection patterns in mice of an avirulent and virulent strain of Semliki Forest virus. Br. J. Exp. Pathol. 1971. 52: 669-677.
39. Ebnet, K., Hausmann, M., Lehmann-Grube, F., Mullbacher, A., Kopf, M., Lamers, M. and Simon, M. M., Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J. 1995. 14: 4230-4239.
40. Heusel, J. W., Wesselschmidt, R. L., Shresta, S., Russell, J. H. and Ley, T. J., Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994. 76: 977-987.
41. Simon, M. M., Hausmann, M., Tran, T., Ebnet, K., Tschopp, J., ThaHla, R. and Mullbacher, A., In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A × B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J. Exp. Med. 1997. 186: 1781-1786.
42. Mullbacher, A., Waring, P., Tha Hla, R., Tran, T., Chin, S., Stehle, T., Museteanu, C. and Simon, M. M., Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc. Natl. Acad. Sci. USA 1999. 96: 13950-13955.
43. Samelson, L. E., Davidson, W. F., Morse, H. C. 3rd and Klausner, R. D., Abnormal tyrosine phosphorylation on T-cell receptor in lymphoproliferative disorders. Nature 1986. 324: 674-676.
44. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994. 76: 969-976.
45. Adachi, M., Suematsu, S., Kondo, T., Ogasawara, J., Tanaka, T., Yoshida, N. and Nagata, S., Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Genet. 1995. 11: 294-300.
46. Rode, M., Balkow, S., Sobek, V., Brehm, R., Martin, P., Kersten, A., Dumrese, T. et al., Perforin and Fas act together in the induction of apoptosis, and are both critical in the clearance of lymphocytic choriomeningitis virus infection. J. Virol. 2004. 78: 12395-12405.
47. + T cells. Science 1990. 248: 1227-1230.
48. Tagawa, Y., Sekikawa, K. and Iwakura, Y., Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J. Immunol. 1997. 159: 1418-1428.
49. Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J. et al., Immune response in mice that lack the interferon-gamma receptor. Science 1993. 259: 1742-1745.
50. Mullbacher, A. and King, N. J., Differential target cell susceptibility to SFV-immune cytotoxic T-cells. Arch. Virol. 1989. 107: 97-109.
51. Selin, L. K., Nahill, S. R. and Welsh, R. M., Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous virus. J. Exp. Med. 1994. 179: 1933-1943.